$172 Million is the total value of Anson Funds Management LP's 54 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 393.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TLRY | TILRAY INC | $99,378,000 | -50.9% | 1,408,812 | 0.0% | 57.72% | -20.1% | |
| UVXY | New | PROSHARES TR IIput | $16,166,000 | – | 197,800 | +100.0% | 9.39% | – |
| SLB | New | SCHLUMBERGER LTDcall | $13,779,000 | – | 381,900 | +100.0% | 8.00% | – |
| DIS | New | DISNEY WALT COcall | $7,127,000 | – | 65,000 | +100.0% | 4.14% | – |
| C | New | CITIGROUP INCcall | $6,091,000 | – | 117,000 | +100.0% | 3.54% | – |
| GS | New | GOLDMAN SACHS GROUP INCcall | $5,429,000 | – | 32,500 | +100.0% | 3.15% | – |
| GOOGL | New | ALPHABET INCcall | $5,225,000 | – | 5,000 | +100.0% | 3.04% | – |
| AGX | New | ARGAN INC | $1,642,000 | – | 43,385 | +100.0% | 0.95% | – |
| BPR | New | BROOKFIELD PROPERTY REIT INCcl a | $1,531,000 | – | 95,000 | +100.0% | 0.89% | – |
| CATS | Sell | CATASYS INC | $1,131,000 | -49.4% | 120,742 | -30.6% | 0.66% | -17.8% |
| AEZS | New | AETERNA ZENTARIS INC | $987,000 | – | 335,781 | +100.0% | 0.57% | – |
| CLI | New | MACK CALI RLTY CORP | $852,000 | – | 43,500 | +100.0% | 0.50% | – |
| HPP | New | HUDSON PAC PPTYS INC | $735,000 | – | 25,306 | +100.0% | 0.43% | – |
| SHIPW | Sell | SEANERGY MARITIME HLDGS CORP*w exp 11/10/202 | $709,000 | -45.0% | 1,409,400 | -1.6% | 0.41% | -10.4% |
| BAM | New | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $614,000 | – | 16,000 | +100.0% | 0.36% | – |
| SLG | New | SL GREEN RLTY CORP | $612,000 | – | 7,750 | +100.0% | 0.36% | – |
| RNN | New | REXAHN PHARMACEUTICALS INC | $565,000 | – | 607,113 | +100.0% | 0.33% | – |
| VLRX | New | VALERITAS HLDGS INC | $563,000 | – | 1,729,620 | +100.0% | 0.33% | – |
| INVH | New | INVITATION HOMES INC | $552,000 | – | 27,500 | +100.0% | 0.32% | – |
| SPG | New | SIMON PPTY GROUP INC NEW | $520,000 | – | 3,100 | +100.0% | 0.30% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $474,000 | – | 219,395 | +100.0% | 0.28% | – |
| NLNK | New | NEWLINK GENETICS CORP | $429,000 | – | 282,262 | +100.0% | 0.25% | – |
| HTBX | New | HEAT BIOLOGICS INC | $413,000 | – | 421,725 | +100.0% | 0.24% | – |
| ONCS | New | ONCOSEC MED INC | $412,000 | – | 643,444 | +100.0% | 0.24% | – |
| SMSI | New | SMITH MICRO SOFTWARE INC | $409,000 | – | 227,032 | +100.0% | 0.24% | – |
| DTEA | New | DAVIDSTEA INC | $385,000 | – | 326,414 | +100.0% | 0.22% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $380,000 | – | 335,931 | +100.0% | 0.22% | – |
| LPT | New | LIBERTY PPTY TRsh ben int | $377,000 | – | 9,000 | +100.0% | 0.22% | – |
| UXIN | New | UXIN LTDcall | $374,000 | – | 76,900 | +100.0% | 0.22% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $346,000 | – | 293,427 | +100.0% | 0.20% | – |
| CYTXZ | CYTORI THERAPEUTICS INC*w exp 05/28/202 | $301,000 | -28.5% | 1,038,600 | 0.0% | 0.18% | +16.7% | |
| New | TRILLIUM THERAPEUTICS INC | $298,000 | – | 174,174 | +100.0% | 0.17% | – | |
| FRAN | New | FRANCESCAS HLDGS CORP | $297,000 | – | 305,900 | +100.0% | 0.17% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $284,000 | – | 79,061 | +100.0% | 0.16% | – |
| RESN | New | RESONANT INC | $280,000 | – | 210,631 | +100.0% | 0.16% | – |
| VIVE | New | VIVEVE MED INC | $263,000 | – | 250,000 | +100.0% | 0.15% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $250,000 | – | 233,392 | +100.0% | 0.14% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $243,000 | – | 1,229,844 | +100.0% | 0.14% | – |
| ACC | New | AMERICAN CAMPUS CMNTYS INC | $207,000 | – | 5,000 | +100.0% | 0.12% | – |
| GTXI | New | GTX INC DEL | $207,000 | – | 265,215 | +100.0% | 0.12% | – |
| SFET | New | SAFE T GROUP LTDsponsored ads | $190,000 | – | 64,090 | +100.0% | 0.11% | – |
| RKDA | New | ARCADIA BIOSCIENCES INC | $175,000 | – | 55,261 | +100.0% | 0.10% | – |
| GERN | New | GERON CORP | $171,000 | – | 171,203 | +100.0% | 0.10% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $158,000 | – | 250,182 | +100.0% | 0.09% | – |
| TYHT | New | SHINECO INC | $94,000 | – | 161,291 | +100.0% | 0.06% | – |
| SYN | New | SYNTHETIC BIOLOGICS INC | $88,000 | – | 156,915 | +100.0% | 0.05% | – |
| EDGE | New | EDGE THERAPEUTICS INC | $78,000 | – | 243,412 | +100.0% | 0.04% | – |
| PHIOW | New | PHIO PHARMACEUTICALS CORP*w exp 12/21/202 | $72,000 | – | 217,023 | +100.0% | 0.04% | – |
| TNXP | New | TONIX PHARMACEUTICALS HLDG C | $68,000 | – | 31,136 | +100.0% | 0.04% | – |
| New | DIFFUSION PHARMACEUTICALS IN | $66,000 | – | 33,120 | +100.0% | 0.04% | – | |
| MDGSW | New | MEDIGUS LTD*w exp 07/23/202 | $55,000 | – | 21,000 | +100.0% | 0.03% | – |
| VBLT | New | VASCULAR BIOGENICS LTD | $45,000 | – | 45,998 | +100.0% | 0.03% | – |
| NSPRZ | INSPIREMD INC*w exp 03/14/202 | $40,000 | -27.3% | 250,000 | 0.0% | 0.02% | +15.0% | |
| XGTI | New | XG TECHNOLOGY INC | $29,000 | – | 94,279 | +100.0% | 0.02% | – |
| RXIIW | Exit | RXI PHARMACEUTICALS CORP NEW*w exp 12/16/202 | $0 | – | -218,023 | -100.0% | -0.09% | – |
| SSYS | Exit | STRATASYS LTD | $0 | – | -100,000 | -100.0% | -0.17% | – |
| PAVMZ | Exit | PAVMED INC*w exp 04/30/202 | $0 | – | -1,124,541 | -100.0% | -0.52% | – |
| ATAX | Exit | AMERICA FIRST MULTIFAMILY INben unit ctf | $0 | – | -1,250,000 | -100.0% | -0.58% | – |
| AMRQQ | Exit | ALTA MESA RES INCcl a | $0 | – | -600,000 | -100.0% | -0.90% | – |
| EYESW | Exit | SECOND SIGHT MED PRODS INC*w exp 03/06/202 | $0 | – | -1,335,561 | -100.0% | -0.91% | – |
| AMRWW | Exit | ALTA MESA RES INC*w exp 03/28/202 | $0 | – | -622,006 | -100.0% | -0.93% | – |
| UBNT | Exit | UBIQUITI NETWORKS INCput | $0 | – | -144,000 | -100.0% | -5.08% | – |
| NVDA | Exit | NVIDIA CORPput | $0 | – | -85,100 | -100.0% | -8.54% | – |
| AMZN | Exit | AMAZON COM INCput | $0 | – | -12,000 | -100.0% | -8.58% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.